BHST

BioHarvest Sciences Inc. (NASDAQ:BHST) is a Canadian biotechnology company founded to revolutionize how botanical compounds are produced for nutraceutical and pharmaceutical applications. Based in Vancouver, Canada, with operations in Israel and the United States, the company has developed a proprietary botanical synthesis platform that enables the cultivation of plant cells in bioreactors rather than traditional farming methods. Since completing its NASDAQ uplisting in 2024, BioHarvest has positioned itself as both a direct-to-consumer wellness brand and a contract development and manufacturing organization (CDMO) serving pharmaceutical and food industry clients.